Cargando…
The Emerging Role of Circulating Tumor DNA in the Management of Breast Cancer
SIMPLE SUMMARY: As breast cancer diagnoses continue to rise among women worldwide, it is important to explore and improve upon methods of diagnosis and surveillance. Liquid biopsies have the potential to become the forefront of such efforts, with circulating tumor DNA (ctDNA) increasingly being stud...
Autores principales: | Shoukry, Mira, Broccard, Sacha, Kaplan, Jamie, Gabriel, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345044/ https://www.ncbi.nlm.nih.gov/pubmed/34359713 http://dx.doi.org/10.3390/cancers13153813 |
Ejemplares similares
-
Management of a Primary Retroperitoneal Yolk Sac Tumor
por: Shoukry, Mira, et al.
Publicado: (2021) -
Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022) -
Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
por: Vlataki, Katerina, et al.
Publicado: (2023) -
Advanced Tumor Imaging Approaches in Human Tumors
por: Nussbaum, Samuel, et al.
Publicado: (2022) -
Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
por: Tellez-Gabriel, Marta, et al.
Publicado: (2020)